Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Critical illness can lead to long-lasting physical and psychological problems, requiring ongoing, specialized care and rehabilitation.

Patients who survive critical illness often face long-lasting physical, mental, and cognitive issues, with many unable to return to work within a year.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Co-trimoxazole may help treat autoimmune diseases.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Retinoids may help treat lupus nephritis and reduce steroid use.

A high fat lard diet may protect against skin fibrosis and affect hair growth.

Older men with late-onset lupus have a higher mortality rate than women.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Patients need better information about the risks of long-term steroid use.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Low dose methotrexate does not increase hair fall and may reduce it.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.